Page last updated: 2024-10-22

amobarbital and Metabolism, Inborn Errors

amobarbital has been researched along with Metabolism, Inborn Errors in 2 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Metabolism, Inborn Errors: Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kalow, W1
Kadar, D1
Inaba, T1
Tang, BK1
Holmes, B1
Good, RA1

Other Studies

2 other studies available for amobarbital and Metabolism, Inborn Errors

ArticleYear
A case of deficiency of N-hydroxylation of amobarbital.
    Clinical pharmacology and therapeutics, 1977, Volume: 21, Issue:5

    Topics: Adolescent; Adult; Aged; Alleles; Amobarbital; Biotransformation; Female; Half-Life; Humans; Hydroxy

1977
Laboratory models of chronic granulomatous disease.
    Journal of the Reticuloendothelial Society, 1972, Volume: 12, Issue:2

    Topics: Amobarbital; Animals; Blood Bactericidal Activity; Chronic Disease; Dehydroepiandrosterone; Dihydrol

1972